Related Experiment Videos
Osteoblast precursor cells are found in CD34+ cells from human bone marrow
1Amgen Inc., Thousand Oaks, California 91320, USA.
Stem Cells (Dayton, Ohio)
|January 1, 1997
Summary
Osteoblast progenitor cells, crucial for bone formation, are significantly enriched in the CD34+ cell population from human bone marrow. These CD34+ cells differentiate into functional osteoblasts, offering new insights into bone regeneration.
Area of Science:
- Stem Cell Biology
- Bone Biology
- Hematopoiesis
Background:
- Osteoblast precursor cells reside in the low-density mononuclear (LDMN) fraction of human bone marrow (BM).
- The presence of CD34, a hematopoietic progenitor cell marker, on osteoblast progenitor cells remains to be elucidated.
Purpose of the Study:
- To investigate the presence of CD34 on osteoblast progenitor cells.
- To determine the frequency and differentiation potential of CD34+ osteoblast progenitor cells.
Main Methods:
- Isolation and culture of LDMN, CD34+, and CD34- cells from human bone marrow.
- Limiting dilution assays to determine osteoblast progenitor frequency.
- Induction of osteoblast differentiation using dexamethasone (DEX).
- Morphological, ultrastructural, and functional analyses of differentiated osteoblasts.
Main Results:
- Osteoblast progenitor frequency was significantly higher in CD34+ cells (1/5,000) compared to LDMN (1/36,000) and CD34- cells (1/33,000).
- CD34+ cells differentiated into morphologically and ultrastructurally normal osteoblasts expressing skeletal markers.
- Differentiated CD34+-derived osteoblasts exhibited functional characteristics, including hormone responsiveness and mineral secretion.
Conclusions:
- Osteoblast progenitor cells are enriched within the CD34+ cell population of human bone marrow.
- CD34+ progenitor cells possess the capacity to differentiate into functional osteoblasts in vitro.
- This finding has implications for understanding bone formation and developing regenerative therapies.